Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • dbrg77
    Junior Member
    • Sep 2010
    • 6

    Why using short reads?

    Hi, everyone. I'm a newbie here.

    I have a question that always baffles me that why NGS only uses short sequence tags?

    Instead sequence the whole DNA fragments, it only sequences the first 25-50 bp of a DNA fragment.

    Is there a particular reason for doing this?

    Thank you!
  • krobison
    Senior Member
    • Nov 2007
    • 734

    #2
    It's what the technology is capable of. Most technologies attain their signal from a clonal population of DNA molecules which are signalling in sync; as this synchronization is lost (dephasing) the noise climbs; eventually noise overwhelms signal. The best review on this is in The challenges of sequencing by synthesis., whose author list features many of the heavy hitters in the field.

    PacBio's SMRT technology (and Helicos' before it) looks at single molecules and therefore does not have a dephasing problem. For PacBio, the problem is apparently that the laser used to observe the sequencing eventually destroys the DNA polymerase that is doing the work, probably via a free radical mechanism. I don't know if Helicos ever figured out what kept their reads very short.

    Note that short is not quite as short these days; SOLiD is getting around 75bp and Illumina on the order of 150 bp. 454 routinely gets 400+ (perhaps soon out to 800) and PacBio 1.5Kb. Still, all sorts of blue sky proposals are aiming at reads of 10s or perhaps 100s or even 1000s of kilobases.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Today, 12:17 PM
    0 responses
    10 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 11:41 AM
    0 responses
    11 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    37 views
    0 reactions
    Last Post SEQadmin2  
    Working...